|
|
Article: Paradigm Therapeutics Limited Raises 12 Million Pounds Sterling in Second Round Funding.
- Article from:
- PR Newswire
- Article date:
- December 9, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, England -- Paradigm Therapeutics Limited ('Paradigm') today announced the successful completion of a second round of private equity funding totalling approximately 12 million pounds sterling. BioMedical Sciences Investment Fund Pte Ltd of Singapore and UK based Technomark Medical Ventures acted as co-lead investors for the round. Other investors included Paradigm's existing UK-based investor Avlar BioVentures Fund I as well as Avlar BioVentures Fund II. Genmab A/S also made a minority investment following the recently established alliance with Paradigm to develop therapeutic antibodies to Paradigm's novel drug targets.
Paradigm Therapeutics, a spin ...